cephalosporin c has been researched along with technetium tc 99m dimercaptosuccinic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, C; Bischoff, G; Buechner, K; Gervaix, A; Girardin, E; Goetschel, P; Hunziker, U; Husarik, D; Molinari, L; Nadal, D; Neuhaus, TJ; Parvex, P; Rudin, C; Stocker, S; Willi, U | 1 |
Kim, JJ; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yoo, KH | 1 |
2 trial(s) available for cephalosporin c and technetium tc 99m dimercaptosuccinic acid
Article | Year |
---|---|
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Ceftibuten; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Injections, Intravenous; Male; Pyelonephritis; Radionuclide Imaging; Technetium Tc 99m Dimercaptosuccinic Acid | 2008 |
The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cicatrix; Female; Fever; Humans; Infant; Kidney; Male; Pyelonephritis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Dimercaptosuccinic Acid; Time Factors; Treatment Outcome; Urinary Tract Infections; Vesico-Ureteral Reflux | 2012 |